As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the data analytics industry, including Health Catalyst (NASDAQ:HCAT) and its peers. Organizations ...

During the last three months, 8 analysts shared their evaluations of Health Catalyst HCAT, revealing diverse outlooks from bullish to bearish. The following table encapsulates their recent ratings ...

Health Catalyst (NASDAQ:HCAT – Free Report) had its target price decreased by Royal Bank of Canada from $9.00 to $7.00 in a research note released on Wednesday morning,Benzinga reports.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Citigroup (NYSE:C) analyst Citigroup maintained a Buy rating on Health Catalyst (NASDAQ:HCAT) on Monday, setting a price target of $55, which is approximately 49.95% above the... Berenberg Bank ...

Health Catalyst, Inc. (HCAT) stock price is 5.63 and Health Catalyst, Inc. (HCAT) 10-day simple moving average is 5.66. Health Catalyst, Inc. (HCAT) stock price is 5.63 and Health Catalyst ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Linda Llewelyn, the Chief People Officer at Health Catalyst , Inc. (NASDAQ:HCAT), recently sold shares of the company, according to a filing with the Securities and Exchange... In a turbulent ...